Exovent
Exovent is a London-based, privately held medical device manufacturer founded in 2020 that develops positive-pressure ventilation systems, serving clinical and emergency-care settings in the United Kingdom.
- Company typePrivate
- Founded2020
- HeadquartersLondon, United Kingdom
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Exovent does
Exovent is a privately held, for-profit medical device manufacturer founded in 2020 and headquartered in London, United Kingdom. Per the firmographics, the company develops medical devices, with positive-pressure ventilation systems identified as a core product line. Positive-pressure ventilation systems deliver pressurized air or oxygen-enriched gas to patients who cannot breathe adequately on their own and are used in clinical settings ranging from intensive care to emergency response; Exovent's specific design, indications, or regulatory status are not disclosed in the available data.
The company's headcount is stated as 11-50 employees, consistent with an early-stage UK MedTech developer. No information on funding rounds, revenue model, pricing, manufacturing capacity, distribution channels, management team, or commercial customers is present in the provided sources. The firm's public-facing web presence (exovent.org) currently renders only a verification/loading page, and there are no observed disclosures regarding regulatory certifications, clinical trials, partnerships, or product certifications.
Given the data thinness, Exovent's business model cannot be characterized beyond its identification as a medical device manufacturer. Whether it operates on a direct-sale, distributor, licensing, or grant-funded basis is unconfirmed. Its customer segments (NHS/private hospitals, emergency services, international markets) are likewise undetermined from the input. The absence of disclosed funding, customers, or management data makes any further substantive characterization unsupported.
Exovent firmographics
Firmographics- Name
- Exovent
- Website
- https://exovent.org
- Company type
- Private
- Founded year
- 2020
- Headcount range
- 11–50 employees
- Short description
- Exovent is a London-based, privately held medical device manufacturer founded in 2020 that develops positive-pressure ventilation systems, serving clinical and emergency-care settings in the United Kingdom.
- Ownership category
- akta.pro rank
Exovent industry classification
Industry- Product category
- Respiratory Care Medical Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Ventilators & Mechanical Ventilation Systems (ICU/Transport/Home) (HLAHAGAC)
- akta.pro secondary industries
- Noninvasive Ventilation Interfaces & Consumables (Masks, Tubing, Humidifiers, Filters) (HLAHAGAG), Home Ventilation, Oxygen Therapy & Respiratory DME Clinical Management (HLAKANAM)
Keywords
Where Exovent is headquartered
LocationHeadquarters
- HQ city
- London
- HQ country
- United Kingdom
- HQ region
- Europe
Markets served
Exovent business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Technology or R&D, Personnel, Operations, Infrastructure
Exovent product offering
Product offeringCore offering
Exovent manufactures medical devices, with a primary focus on positive-pressure ventilation systems designed for respiratory support. The company develops and produces these clinical respiratory care devices as its core product line.
Differentiator
Problem solved
Functional benefit
Products and services
- Positive-Pressure Ventilation System
Companies that use Exovent
Customer profileIdeal customer profiles1 record
Exovent technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Exovent partnerships and signals
Strategic signalRecent moves1 record
Exovent competitors and assessment
Company assessmentDirect peers
- Drägerwerk: Global manufacturer of ICU ventilators and anesthesia delivery systems. Competes head-on in the mechanical ventilation category, particularly in European hospital channels that overlap Exovent's London positioning.
- Hamilton Medical: Swiss-headquartered specialist in mechanical ventilators for ICU and transport. Direct competitor in the same core product category (mechanical ventilation systems) Exovent is targeting.
- Getinge (Maquet): Swedish MedTech group whose Maquet brand supplies ICU ventilators, anesthesia machines, and critical-care infrastructure. Same end-customer (hospital ICUs) and same product category as Exovent.
- Vyaire Medical: Pure-play respiratory care company spun out of Becton Dickinson; manufactures ICU and transport ventilators. Closest pure-play comparable to Exovent in scale and specialisation.
Broad incumbents
- Medtronic (Puritan Bennett): Medtronic markets the Puritan Bennett line of mechanical ventilators — one of the most entrenched ICU-ventilation brands globally. Overlapping category, but Medtronic is a diversified medtech incumbent rather than a niche specialist.
- ResMed: Global leader in sleep-disordered breathing and non-invasive ventilation (BiPAP, home ventilators). Comparable in non-invasive respiratory care but broader portfolio and home/sleep focus.
- Philips Respironics: Philips is a leading player in hospital and home ventilation, including non-invasive and bi-level positive airway pressure devices — adjacent and partially overlapping with Exovent's stated focus.
Emerging players
- Intersurgical: UK-based manufacturer of respiratory care products including ventilation interfaces and breathing circuits. Geographic peer (UK) and overlapping category, especially on the consumables/interfaces side.
- Cognita Labs: Early-stage developer of novel non-invasive respiratory support technology. Comparable in that it represents the wave of small, modality-differentiating entrants trying to displace traditional mechanical ventilation — same competitive set as Exovent.
- BMC Medical: Chinese manufacturer of non-invasive ventilators, CPAP/BiPAP devices, and respiratory interfaces. Comparable in modality (non-invasive positive-pressure ventilation) and serves the same clinical use cases.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat2 records
Key risks5 records
Key highlights4 records
Customer concentration
Exovent social profiles
Digital presenceExovent financial estimates
Financial estimateRevenue estimate
Valuation estimate
Exovent leadership team
Management profileNumber of profiles
Exovent funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Exovent M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Exovent
What does Exovent do?
Exovent manufactures medical devices, with a primary focus on positive-pressure ventilation systems designed for respiratory support. The company develops and produces these clinical respiratory care devices as its core product line.
When was Exovent founded?
Exovent was founded in 2020. It employs 11 to 50 people.
Where is Exovent based?
Exovent is headquartered in London, United Kingdom, in the Europe region.
Who are Exovent's main competitors?
Direct peers on record are Drägerwerk, Hamilton Medical, Getinge (Maquet) and Vyaire Medical. Broad incumbents are Medtronic (Puritan Bennett), ResMed and Philips Respironics. Emerging players are Intersurgical, Cognita Labs and BMC Medical.
Does Exovent have an API?
No public API is recorded for Exovent.
What industry is Exovent in?
Exovent's product category is Respiratory Care Medical Devices. Its primary akta.pro industry code is HLAHAGAC, Ventilators & Mechanical Ventilation Systems (ICU/Transport/Home), with a secondary code of HLAHAGAG, Noninvasive Ventilation Interfaces & Consumables (Masks, Tubing, Humidifiers, Filters). Its NAICS code is 334510 and its SIC code is 3845.